Recombinant Bacillus cereus S-adenosylmethionine decarboxylase proenzyme (speH)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice is specifically requested in advance. Dry ice shipments incur additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline for your reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is finalized during production. If a specific tag is required, please inform us for preferential development.
Synonyms
speH; BCE_4712; S-adenosylmethionine decarboxylase proenzyme; AdoMetDC; SAMDC; EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase beta chain; S-adenosylmethionine decarboxylase alpha chain]
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-65
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Bacillus cereus (strain ATCC 10987 / NRS 248)
Target Names
speH
Target Protein Sequence
MDTMDTMGRH VIAELWDCDF DKLNDMPYIE QLFVDAALRA GAEVREVAFH KFAPQGVSGV VIISE
Uniprot No.

Target Background

Function
This enzyme catalyzes the decarboxylation of S-adenosylmethionine to S-adenosylmethioninamine (dcAdoMet), providing the propylamine donor necessary for spermine and spermidine biosynthesis from putrescine.
Database Links

KEGG: bca:BCE_4712

Protein Families
Prokaryotic AdoMetDC family, Type 1 subfamily

Q&A

What is S-adenosylmethionine decarboxylase proenzyme (speH) and what is its function in polyamine biosynthesis?

S-adenosylmethionine decarboxylase proenzyme (speH) is a pyruvoyl-dependent enzyme that catalyzes the decarboxylation of S-adenosylmethionine to S-adenosylmethioninamine (dcAdoMet), which serves as the aminopropyl group donor in the biosynthesis of polyamines such as spermidine and spermine . In the polyamine biosynthetic pathway, dcAdoMet produced by AdoMetDC/SpeD is combined with putrescine by spermidine synthase (SpdSyn/SpeE) to form spermidine .

The enzyme is initially synthesized as a proenzyme that undergoes autocatalytic processing to generate its active form with a pyruvoyl cofactor. This autocatalytic processing reaction creates new α- and β-subunits, with the internal serine-derived pyruvoyl cofactor positioned at the N-terminus of the α-subunit .

What is the relationship between speH and Bacillus cereus pathogenicity?

While speH itself is not directly linked to B. cereus pathogenicity in the provided search results, it's part of the polyamine biosynthesis pathway which can impact bacterial growth and survival. B. cereus is a foodborne pathogen capable of causing food poisoning with a variety of symptoms, particularly in ready-to-eat (RTE) foods that may not undergo heat sterilization before consumption .

Research has shown that 35% of tested retail RTE food samples were positive for B. cereus, with significant proportions of isolated strains harboring various enterotoxin-encoding genes: 39% contained the hblACD gene cluster and 83% had the nheABC gene cluster . The cytK gene associated with severe food poisoning was present in 68% of isolates, and approximately 7% harbored the emetic toxin-encoding gene cesB .

Understanding the relationship between metabolic enzymes like speH and virulence factors requires further research, particularly regarding how polyamine biosynthesis might influence toxin production or bacterial survival under various environmental conditions.

How can recombinant Bacillus cereus speH be expressed and purified for research purposes?

Recombinant B. cereus speH can be successfully expressed in various host systems, with E. coli being the most common. Based on established protocols for similar B. cereus proteins, the following methodology is recommended:

Expression System Selection:

  • E. coli is the most widely used host for recombinant B. cereus protein expression

  • Alternative expression hosts include yeast, baculovirus, or mammalian cell systems depending on experimental requirements

Genetic Engineering Process:

  • Amplify the speH gene from B. cereus genomic DNA using PCR with appropriate primers designed to include restriction enzyme sites for subsequent cloning

  • Digest the PCR product with appropriate restriction enzymes (e.g., NdeI/XhoI as used for similar B. cereus proteins)

  • Ligate the digested fragment into an expression vector such as pRSFduet or another T7 promoter-based vector

  • Transform the resulting construct into a suitable E. coli strain such as T7 Express competent cells

Protein Expression Protocol:

  • Grow transformed E. coli cells under optimized conditions until reaching appropriate optical density

  • Induce protein expression with IPTG or another suitable inducer for the selected expression system

  • Harvest cells and prepare cell-free extract (CFE) by cell disruption techniques

Purification Strategy:
For His-tagged constructs:

  • Subject the CFE to affinity chromatography using Ni-NTA columns

  • Elute the bound protein with an imidazole gradient

  • Verify protein purity using SDS-PAGE, targeting ≥85% purity

  • Optional additional purification steps may include ion exchange or size exclusion chromatography

The expected molecular weight of recombinant B. cereus speH is approximately 8-10 kDa, with specific weight varying based on construct design and tag inclusion .

What analytical methods can be used to characterize recombinant speH enzyme activity?

Several analytical approaches can be employed to characterize the enzymatic activity of recombinant speH:

Decarboxylation Activity Assay:

  • Measure the conversion of S-adenosylmethionine to decarboxylated S-adenosylmethionine (dcAdoMet)

  • Common detection methods include:

    • Radiometric assays using 14C-labeled S-adenosylmethionine and measuring released 14CO2

    • HPLC-based assays measuring substrate depletion and product formation

    • Coupled enzymatic assays that link decarboxylation to spectrophotometrically detectable reactions

Kinetic Parameter Determination:

  • Perform enzyme reactions at varying substrate concentrations (typically 0.2-8 mM range)

  • Plot initial velocities versus substrate concentration

  • Create Lineweaver-Burk plots (1/v vs 1/[S]) to determine:

    • Km (Michaelis constant)

    • Vmax (maximum reaction velocity)

    • kcat (turnover number)

    • kcat/Km (catalytic efficiency)

Autocatalytic Processing Analysis:

  • Monitor the conversion of proenzyme to mature enzyme (α and β subunits) using:

    • SDS-PAGE to observe the appearance of processed subunits

    • Mass spectrometry to precisely characterize the cleavage site and pyruvoyl formation

    • N-terminal sequencing to confirm the identity of processed subunits

Structural Characterization:

  • Circular dichroism (CD) spectroscopy to assess secondary structure

  • Thermal shift assays to determine protein stability

  • X-ray crystallography or cryo-EM for three-dimensional structure determination

How can speH be distinguished from other related decarboxylases in bacterial samples?

Distinguishing speH from other related decarboxylases in bacterial samples requires a combination of genetic, proteomic, and biochemical approaches:

Genetic Approaches:

  • PCR amplification using speH-specific primers

  • Whole genome sequencing followed by bioinformatic analysis to identify the speH gene

  • Comparative genetic analysis to distinguish speH from functionally related genes, such as those encoding L-arginine decarboxylases or L-ornithine decarboxylases that emerged through neofunctionalization of AdoMetDC/SpeD

Proteomic Approaches:

  • Mass spectrometry-based identification of diagnostic peptides unique to speH

    • For Bacillus cereus group species identification, LC-ESI MS/MS analysis after trypsin digestion has been successfully employed

    • This approach can be adapted to specifically identify speH-derived peptides

  • Western blot analysis using speH-specific antibodies or tag-based detection systems

    • For recombinant proteins, strep tag or His tag can facilitate specific detection

Biochemical Approaches:

  • Substrate specificity assays to distinguish between:

    • S-adenosylmethionine decarboxylase activity (speH)

    • L-arginine decarboxylase activity

    • L-ornithine decarboxylase activity

  • Inhibitor profiling using specific inhibitors of each decarboxylase type

The distinction between these related decarboxylases is particularly important given the evolutionary relationships revealed through phylogenetic analysis, which has shown that L-arginine decarboxylases emerged at least three times from AdoMetDC/SpeD, while L-ornithine decarboxylases arose only once, potentially from AdoMetDC/SpeD-derived L-arginine decarboxylases .

What are the evolutionary implications of speH neofunctionalization in bacterial systems?

The neofunctionalization of S-adenosylmethionine decarboxylase (speH) represents a fascinating example of enzyme evolution with significant implications for understanding bacterial metabolic diversity:

Evolutionary Pathways:
Phylogenetic analysis has revealed that:

  • L-arginine decarboxylases emerged at least three times independently from AdoMetDC/SpeD

  • L-ornithine decarboxylases arose only once, potentially derived from AdoMetDC/SpeD-derived L-arginine decarboxylases

This evolutionary pattern demonstrates unexpected plasticity in polyamine metabolism across bacterial species and suggests that:

  • Functional diversification of decarboxylases occurred multiple times throughout bacterial evolution

  • Horizontal gene transfer appears to be the predominant mechanism for disseminating these neofunctionalized genes across bacterial species

  • The ability to utilize different substrates (S-adenosylmethionine, L-arginine, L-ornithine) provides metabolic flexibility that may confer adaptive advantages in various environmental niches

Novel Fusion Proteins:
Particularly significant is the discovery of fusion proteins combining bona fide AdoMetDC/SpeD with homologous L-ornithine decarboxylases, creating proteins with two internal protein-derived pyruvoyl cofactors . These fusion proteins suggest a plausible evolutionary model for the development of eukaryotic AdoMetDC and represent an unprecedented example of dual cofactor utilization in a single protein.

This finding has implications for understanding:

  • The modular nature of enzyme evolution

  • Potential for engineering novel bifunctional enzymes

  • Evolutionary pathways connecting prokaryotic and eukaryotic enzyme systems

How do experimental conditions affect recombinant speH stability and activity?

Optimizing experimental conditions is crucial for maintaining stability and maximizing activity of recombinant speH. Key considerations include:

Buffer Composition Effects:

  • pH: The optimal pH range for speH activity and stability should be experimentally determined, typically between pH 7.0-8.5

  • Salt concentration: Ionic strength can significantly impact enzyme stability and activity

  • Reducing agents: Addition of DTT or β-mercaptoethanol may be necessary to maintain any critical thiol groups in reduced form

  • Glycerol: Addition of 5-50% glycerol is recommended for long-term storage

Temperature Considerations:

  • Storage temperature: -20°C to -80°C for extended storage

  • Working temperature: Maintain aliquots at 4°C for up to one week

  • Reaction temperature: Optimal temperature for enzymatic activity must be determined experimentally

Freeze-Thaw Stability:

  • Repeated freezing and thawing is not recommended

  • Working aliquots should be prepared to minimize freeze-thaw cycles

Reconstitution Guidelines:
For lyophilized protein:

  • Briefly centrifuge vial before opening

  • Reconstitute in deionized sterile water to 0.1-1.0 mg/mL

  • Add 5-50% glycerol (final concentration) for long-term storage

  • Aliquot and store at -20°C/-80°C

Shelf Life Expectations:

  • Liquid form: approximately 6 months at -20°C/-80°C

  • Lyophilized form: approximately 12 months at -20°C/-80°C

What approaches can be used to study the interactions between speH and other enzymes in the polyamine biosynthesis pathway?

Investigating the interactions between speH and other enzymes in the polyamine biosynthesis pathway requires a combination of biochemical, biophysical, and cellular approaches:

Protein-Protein Interaction Studies:

  • Co-immunoprecipitation (Co-IP) to identify physical interactions between speH and other pathway enzymes

  • Pull-down assays using tagged recombinant proteins

  • Surface plasmon resonance (SPR) to quantify binding kinetics

  • Isothermal titration calorimetry (ITC) to determine thermodynamic parameters of interactions

  • Yeast two-hybrid screening or bacterial two-hybrid systems for in vivo interaction detection

Structural Biology Approaches:

  • X-ray crystallography of enzyme complexes

  • Cryo-electron microscopy for larger complexes

  • Small-angle X-ray scattering (SAXS) to study solution structures

  • NMR spectroscopy for dynamic interaction studies

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to identify interaction interfaces

Metabolic Flux Analysis:

  • Isotope labeling experiments to track metabolite flow through the polyamine pathway

  • Quantitative metabolomics to measure changes in metabolite levels when speH or interacting enzymes are manipulated

  • Computational modeling of the polyamine biosynthesis pathway to predict enzyme interactions and regulatory mechanisms

Genetic Approaches:

  • Construction of gene knockouts or conditional expression systems

  • Analysis of synthetic lethal or synthetic sick interactions

  • Suppressor screens to identify genetic interactions

  • CRISPR-Cas9 gene editing to create specific mutations that disrupt putative interaction surfaces

Cellular Localization Studies:

  • Fluorescence microscopy with tagged proteins to examine co-localization

  • Proximity ligation assays (PLA) to detect protein interactions in situ

  • Subcellular fractionation followed by Western blotting or activity assays

How can tables be effectively used to organize and present speH research data?

Effective data organization and presentation through tables is essential for communicating research findings on speH. Based on best practices in qualitative research , the following table formats are recommended for speH research:

Table 1: Data Sources Table for speH Characterization

Data TypeDescriptionQuantityContribution to Findings
Recombinant protein preparationsPurified speH expressed in E. colin=XPrimary source for enzymatic assays
Mass spectrometry analysesLC-MS/MS of tryptic digestsn=XIdentification of post-translational modifications
Kinetic measurementsDecarboxylation assays at varying substrate concentrationsn=XDetermination of kinetic parameters
Structural analysesX-ray crystallography datasetsn=XElucidation of three-dimensional structure

Table 2: Concept-Evidence Table for speH Processing

ConceptDescriptionSupporting EvidenceData Source
Autocatalytic cleavageSelf-processing of proenzyme to generate α and β subunitsSDS-PAGE showing appearance of processed subunitsGel electrophoresis
Pyruvoyl cofactor formationGeneration of catalytic pyruvoyl group from serine residueMass shift corresponding to dehydration and rearrangementMass spectrometry
Processing kineticsTime-dependent conversion of proenzyme to mature formTime-course of processing under various conditionsActivity assays, SDS-PAGE

Table 3: Cross-Case Analysis Table for Comparison of speH from Different Bacillus Species

SpeciesProtein LengthSequence Identity to B. cereus speHKey Distinguishing FeaturesEnzymatic Activity (U/mg)
B. cereusX amino acids100%Reference sequenceX
B. thuringiensisX amino acidsX%[Specific differences]X
B. anthracisX amino acidsX%[Specific differences]X
B. mycoidesX amino acidsX%[Specific differences]X

Table 4: Typologically Ordered Table for speH Substrate Specificity

SubstrateRelative Activity (%)Km (mM)kcat (s-1)kcat/Km (M-1s-1)
S-adenosylmethionine100XXX
S-adenosylhomocysteineXXXX
MethylthioadenosineXXXX
[Other substrate analogs]XXXX

These table formats help ensure research trustworthiness by:

  • Providing transparent accounting of data sources and analytical processes

  • Facilitating systematic comparison across experimental conditions

  • Clearly linking concepts to supporting evidence

  • Enabling readers to independently assess the robustness of findings

What are the potential applications of recombinant speH in diagnostic or therapeutic contexts?

Recombinant speH has several potential applications in both diagnostic and therapeutic contexts:

Diagnostic Applications:

  • Bacillus cereus Identification

    • Development of mass spectrometry-based identification methods using speH-derived diagnostic peptides

    • Similar approaches have been successful in distinguishing between closely related Bacillus cereus group species, which are genetically very similar and difficult to differentiate using conventional methods

    • Potential for rapid food safety testing, given that B. cereus is a common food contaminant with 35% prevalence in ready-to-eat foods

  • Biomarker Development

    • speH activity or abundance could serve as a biomarker for B. cereus contamination levels

    • Quantitative analysis could correlate with bacterial load in food samples

    • Integration into multiplex detection systems for foodborne pathogens

Therapeutic Applications:

  • Antimicrobial Drug Target

    • As a critical enzyme in polyamine biosynthesis, speH represents a potential target for antimicrobial development

    • Polyamines are essential for bacterial growth and virulence, making their biosynthetic pathways attractive targets

    • Structure-based drug design could yield specific inhibitors of B. cereus speH

  • Vaccine Development

    • Recombinant speH could be explored as a component of subunit vaccines against B. cereus

    • Similar approaches using recombinant proteins have been successful, as demonstrated by the development of bifunctional single-chain antibodies against B. cereus spores

  • Enzyme Replacement Therapies

    • Understanding speH function could inform development of enzyme replacement therapies for human disorders involving S-adenosylmethionine decarboxylase deficiency

  • Polyamine Metabolism Modulation

    • Engineered speH variants could be developed to modulate polyamine levels in various contexts

    • Potential applications in cancer research, where polyamine metabolism is often dysregulated

The development of these applications requires careful consideration of:

  • Specificity for bacterial versus human enzymes

  • Stability under relevant environmental or physiological conditions

  • Scalability of recombinant production systems

  • Regulatory requirements for diagnostic or therapeutic use

What are common challenges in recombinant speH expression and how can they be addressed?

Researchers may encounter several challenges when expressing recombinant B. cereus speH. The following troubleshooting guide addresses common issues and their solutions:

Low Expression Levels:

  • Problem: Poor yield of recombinant speH protein

  • Potential Solutions:

    • Optimize codon usage for the expression host

    • Test different expression vectors with various promoter strengths

    • Evaluate alternative E. coli strains (BL21, Rosetta, Arctic Express)

    • Adjust induction conditions (IPTG concentration, temperature, duration)

    • Consider fusion partners that enhance solubility (MBP, SUMO, TrxA)

Inclusion Body Formation:

  • Problem: speH forms insoluble aggregates

  • Potential Solutions:

    • Lower expression temperature (16-20°C)

    • Reduce inducer concentration

    • Co-express with molecular chaperones (GroEL/GroES, DnaK/DnaJ)

    • Develop refolding protocols if inclusion body purification is necessary

    • Test different solubilizing tags or fusion partners

Incomplete Processing:

  • Problem: Recombinant speH fails to undergo proper autocatalytic processing

  • Potential Solutions:

    • Ensure correct translation of the processing site

    • Optimize buffer conditions to promote self-processing

    • Adjust incubation time and temperature for processing

    • Consider engineered constructs with enhanced processing efficiency

Protein Instability:

  • Problem: Rapid degradation of expressed protein

  • Potential Solutions:

    • Add protease inhibitors during purification

    • Use E. coli strains deficient in specific proteases

    • Optimize storage conditions (add glycerol, avoid freeze-thaw cycles)

    • Engineer stabilizing mutations based on structural analysis

Inconsistent Activity:

  • Problem: Variable enzymatic activity between preparations

  • Potential Solutions:

    • Standardize purification protocols

    • Establish rigorous quality control metrics

    • Ensure complete removal of inhibitory contaminants

    • Validate proper folding using biophysical techniques

How can researchers validate the authenticity and activity of purified recombinant speH?

Comprehensive validation of recombinant speH requires multiple complementary approaches:

Identity Confirmation:

  • SDS-PAGE Analysis

    • Verify expected molecular weight (both proenzyme and processed forms)

    • Compare with theoretical molecular weight from sequence data

  • Mass Spectrometry

    • Peptide mass fingerprinting after trypsin digestion

    • Intact mass analysis to confirm molecular weight and processing state

    • Analysis of post-translational modifications, particularly pyruvoyl formation

  • Western Blotting

    • Using antibodies specific to speH

    • Detection via epitope tags if incorporated (His tag, Strep tag)

  • N-terminal Sequencing

    • Confirm identity of processed α and β subunits

    • Verify correct processing site

Purity Assessment:

  • Densitometry of SDS-PAGE Gels

    • Aim for ≥85% purity as typically required for recombinant proteins

  • Size Exclusion Chromatography

    • Assess homogeneity and oligomeric state

    • Detect aggregation or degradation products

  • Dynamic Light Scattering

    • Measure particle size distribution

    • Identify presence of aggregates

Functional Validation:

  • Enzymatic Activity Assays

    • Measure decarboxylation of S-adenosylmethionine

    • Compare specific activity to published values or internal standards

  • Thermal Shift Assays

    • Assess protein stability and proper folding

    • Monitor effects of different buffer conditions

  • Circular Dichroism

    • Evaluate secondary structure content

    • Compare with predicted structural elements

  • Processing Kinetics

    • Monitor autocatalytic conversion from proenzyme to mature form

    • Confirm generation of the pyruvoyl cofactor

Establishing a standardized validation workflow ensures consistency between preparations and builds confidence in experimental results derived from the recombinant protein.

What are promising future research directions for speH structure-function studies?

Several promising research directions could significantly advance our understanding of speH:

Structural Biology Frontiers:

  • High-Resolution Structure Determination

    • Crystal structures of B. cereus speH in different states (proenzyme, mature enzyme, substrate-bound)

    • Cryo-EM structures of larger complexes with pathway enzymes

    • Time-resolved structural studies of the autocatalytic processing mechanism

  • Comparative Structural Analysis

    • Structural comparison with other bacterial AdoMetDCs

    • Analysis of structural differences with neofunctionalized L-arginine and L-ornithine decarboxylases

    • Investigation of the unique dual-pyruvoyl fusion proteins identified in some bacterial species

Mechanistic Investigations:

  • Autocatalytic Processing

    • Detailed kinetic and thermodynamic analysis of the processing reaction

    • Identification of critical residues using site-directed mutagenesis

    • Development of methods to control or modulate processing

  • Catalytic Mechanism

    • Quantum mechanical/molecular mechanical (QM/MM) simulations of the decarboxylation reaction

    • Investigation of transition states and energy barriers

    • Analysis of substrate specificity determinants

Evolutionary Studies:

  • Comprehensive Phylogenetic Analysis

    • Expanded sampling of speH across bacterial species

    • Detailed analysis of horizontal gene transfer events

    • Investigation of selection pressures driving speH evolution

  • Experimental Evolution

    • Directed evolution to alter substrate specificity

    • Selection experiments under varying polyamine availabilities

    • Reconstruction of ancestral sequences to test evolutionary hypotheses

Systems Biology Approaches:

  • Metabolic Modeling

    • Integration of speH into whole-cell models of B. cereus metabolism

    • Flux balance analysis to predict effects of speH perturbation

    • Assessment of polyamine homeostasis mechanisms

  • Multi-omics Studies

    • Correlation of speH expression with transcriptomic, proteomic, and metabolomic data

    • Network analysis of polyamine metabolism regulation

    • Response to environmental perturbations affecting polyamine requirements

How might emerging technologies enhance speH research and applications?

Emerging technologies offer exciting opportunities to advance speH research:

Advanced Structural Biology Techniques:

  • AlphaFold and Related AI Methods

    • Prediction of speH structures from sequences across species

    • Modeling of protein-protein interactions

    • Prediction of effects of mutations on structure and function

  • Single-Molecule Studies

    • FRET-based analysis of conformational changes during catalysis

    • Optical tweezers to study protein folding and stability

    • Single-molecule enzymology to detect reaction intermediates

Synthetic Biology Approaches:

  • Cell-Free Expression Systems

    • Rapid production and screening of speH variants

    • High-throughput biochemical characterization

    • Incorporation of non-canonical amino acids for enhanced functionality

  • Genome Engineering

    • CRISPR-Cas9 modification of speH in B. cereus

    • Creation of conditional expression systems

    • Engineering of synthetic polyamine biosynthesis pathways

Analytical Advances:

  • Native Mass Spectrometry

    • Analysis of intact protein complexes

    • Detection of non-covalent interactions

    • Monitoring of post-translational modifications

  • Advanced Imaging

    • Super-resolution microscopy to visualize enzyme localization

    • Correlative light and electron microscopy for structural context

    • Label-free imaging techniques to avoid perturbation of function

Computational Methods:

  • Machine Learning for Enzyme Engineering

    • Prediction of mutations that enhance stability or alter specificity

    • Design of optimal expression constructs

    • Analysis of complex datasets from high-throughput experiments

  • Molecular Dynamics Simulations

    • Microsecond to millisecond simulations of conformational dynamics

    • Analysis of substrate binding and product release

    • Investigation of allosteric regulation mechanisms

Biomedical Applications:

  • Targeted Drug Delivery

    • speH-derived peptides as targeting moieties

    • Polyamine pathway modulators in anticancer therapies

    • Bacterial-specific inhibitors as novel antimicrobials

  • Diagnostic Platforms

    • Biosensor development using engineered speH variants

    • Point-of-care testing for B. cereus contamination

    • Integration with microfluidic systems for automated analysis

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.